Skip to main content
. Author manuscript; available in PMC: 2014 Jan 14.
Published in final edited form as: Neuropharmacology. 2013 Apr 19;72:236–249. doi: 10.1016/j.neuropharm.2013.04.015

Table 1.

The hormone replacements administered to Sham and Ovx mice prior to a cocaine challenge. Shams received vehicle for the same time-frame as hormone-replaced Ovx mice. All injections were given in the morning. All mice received a final injection of vehicle or hormone before being placed into locomotor boxes for habituation. For the 30 min versus 2 day replacement study, mice instead received their final injection after the saline treatment during testing, 30 min prior to the COC injection. E2 = 17β-estradiol; PPT = 4,4′,4″-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol; DPN = 2,3-bis(4-Hydroxyphenyl)-propionitrile; N/A = not applicable.

Hormone treatment Length of replacement Dose Injected volume Activated ER(s)
Vehicle 2 days N/A 100 μL N/A
30 min E2 30 min 3 μg once 100 μL α, β
2 Day/High E2 2 days 3 μg/day 100 μL α, β
Medium E2 2 days 0.3 μg/day 100 μL α, β
Low E2 2 days 0.03 μg/day 100 μL α, β
PPT 2 days 2 mg/kg/day 4 mL/kg α
DPN 2 days 8 mg/kg/day 4 mL/kg β